Arthritis &Rheumatology, EarlyView.Objective The optimal treatment strategy for rheumatoid arthritis–associated interstitial lung disease (RA‐ILD) remains uncertain, and direct comparative data between biologics are limited. This study aimed to evaluate the effectiveness and safety of abatacept compared with rituximab in patients with RA‐ILD.
Po‐Cheng Shih +3 more
wiley +1 more source
Impact of biannual azithromycin on weight-for-age z-score among infants in the AVENIR cluster-randomised trial. [PDF]
BMJ Paediatr OpenPeterson B +21 more
europepmc +1 more source
EFFECTIVENESS OF PILATES AND CAMELLIA SINENSIS SUPPLEMENTATION ON CARDIOMETABOLIC RISK FACTORS AND REDOX MARKERS IN POSTMENOPAUSAL WOMEN: A PLACEBO-CONTROLLED, RANDOMIZED TRIAL [PDF]
, 2017 Silvana Junges +6 more
openalex +1 more source
A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritis
Arthritis &Rheumatology, Accepted Article.Background Individuals with serum elevations of anti‐cyclic citrullinated peptide (anti‐CCP) antibodies are at increased risk for future rheumatoid arthritis (RA). No pharmacologic interventions have been approved for the prevention of RA in such ‘at‐risk’ individuals. However, hydroxychloroquine (HCQ) is used without supporting clinical trial evidence.
Kevin D. Deane +33 more
wiley +1 more source
Placebo in Functional Neurological Disorders: Promise and Controversy. [PDF]
Healthcare (Basel)Szejko N +10 more
europepmc +1 more source
Safety and efficacy of ketorolac in improving the prognosis of acute type A aortic dissection patients: a protocol of a randomized, double-blinded, and placebo-controlled study [PDF]
Z.T. Lv +7 more
openalex +1 more source
Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis.
New England Journal of Medicine, 2012 R. Gold +10 more
semanticscholar +1 more source
A Randomized, Placebo‐Controlled Trial of Hydroxychloroquine in Incomplete Lupus
Arthritis &Rheumatology, EarlyView.Objective Patients with features of systemic lupus erythematosus (SLE) who do not fulfill classification criteria can be designated as incomplete lupus erythematosus (ILE). This condition includes individuals with a high risk of progression to SLE. Treatment of ILE may reduce symptoms, severity, and incidence of SLE.
Nancy J. Olsen +14 more
wiley +1 more source
Efficacy of a multi-nutrient dietary supplement on improving decision fatigue in video gamers. [PDF]
Front NutrSeesurn B, Batllori R, Watson SN.
europepmc +1 more source